A recent study found that acute and chronic hypoxia in the cellular microenvironment may decrease HR protein expression and its function, which sensitizes cells to PARP inhibition.122 This finding can be applied in the treatment of BRCA1/2-mutated tumor cells that are resistant to PARP inhibitors. The gene discussed is PARP1; the disease is neoplasm.